From the western blot data, baicalin treatment dramatically decreased the levels of Cyclin D1, Cyclin E1, Cyclin B1 and p-Akt (Ser473) in all two CRC cell lines. This evidence concerns the gene CCNE1 and colorectal carcinoma.